These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24024631)

  • 1. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods.
    Charman CR; Venn AJ; Ravenscroft JC; Williams HC
    Br J Dermatol; 2013 Dec; 169(6):1326-32. PubMed ID: 24024631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
    Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
    Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Oriented Eczema Measure score: A Useful Tool for Web-Based Surveys in Patients with Atopic Dermatitis.
    Kido-Nakahara M; Nakahara T; Yasukochi Y; Ulzii D; Furue M
    Acta Derm Venereol; 2020 May; 100(10):adv00159. PubMed ID: 32449786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
    Silverberg JI; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Fuxench ZC; Simpson EL
    Br J Dermatol; 2020 Jan; 182(1):104-111. PubMed ID: 30972740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis.
    Silverberg JI; Gelfand JM; Margolis DJ; Fonacier L; Boguniewicz M; Schwartz LB; Simpson E; Grayson MH; Ong PY; Fuxench ZCC
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):464-468.e3. PubMed ID: 30003968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness.
    Santer M; Ridd MJ; Francis NA; Stuart B; Rumsby K; Chorozoglou M; Becque T; Roberts A; Liddiard L; Nollett C; Hooper J; Prude M; Wood W; Thomas KS; Thomas-Jones E; Williams HC; Little P
    BMJ; 2018 May; 361():k1332. PubMed ID: 29724749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Patient-Oriented Eczema Measure in young children: responsiveness and minimal clinically important difference.
    Gaunt DM; Metcalfe C; Ridd M
    Allergy; 2016 Nov; 71(11):1620-1625. PubMed ID: 27232584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Patient-Oriented Eczema Measure: estimating the minimal important change in an outpatient clinic cohort.
    Yew YW; Zhao X; Apfelbacher CJ
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1273-1279. PubMed ID: 31793052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity strata for five patient-reported outcomes in adults with atopic dermatitis.
    Vakharia PP; Chopra R; Sacotte R; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Simpson EL; Silverberg JI
    Br J Dermatol; 2018 Apr; 178(4):925-930. PubMed ID: 29048751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atopic Dermatitis in Children in the General Population: Baseline Characteristics, Medication Use, and Severity Measures in the Rotterdam Eczema Study.
    van Halewijn KF; van der Most F; Bohnen AM; Pasmans SGMA; Bindels PJE; Elshout G
    Dermatitis; 2024; 35(1):61-69. PubMed ID: 37015063
    [No Abstract]   [Full Text] [Related]  

  • 11. How should minimally important change scores for the Patient-Oriented Eczema Measure be interpreted? A validation using varied methods.
    Howells L; Ratib S; Chalmers JR; Bradshaw L; Thomas KS;
    Br J Dermatol; 2018 May; 178(5):1135-1142. PubMed ID: 29355894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding emollient bath additives to standard eczema management for children with eczema: the BATHE RCT.
    Santer M; Rumsby K; Ridd MJ; Francis NA; Stuart B; Chorozoglou M; Roberts A; Liddiard L; Nollett C; Hooper J; Prude M; Wood W; Thomas-Jones E; Becque T; Thomas KS; Williams HC; Little P
    Health Technol Assess; 2018 Oct; 22(57):1-116. PubMed ID: 30362939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry.
    Guttman-Yassky E; Bar J; Rothenberg-Lausell C; Eichenfield L; Grada A; Abuabara K; Chapman M; Calimlim B; Wegzyn C; Gamelli A; Krueger W; Munoz B; Knapp K; Faller R; Crawford J; Silverberg J
    J Drugs Dermatol; 2023 Apr; 22(4):344-354. PubMed ID: 37026893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and influence of "not relevant" responses on the Dermatology Life Quality Index among adults with atopic dermatitis.
    Barbieri JS; Chiesa Fuxench ZC; Shin DB; Takeshita J
    Qual Life Res; 2021 Jun; 30(6):1705-1713. PubMed ID: 33538979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis.
    Simpson EL; de Bruin-Weller M; Bansal A; Chen Z; Nelson L; Whalley D; Prescilla R; Guillemin I; Delevry D
    Dermatol Ther (Heidelb); 2021 Aug; 11(4):1415-1422. PubMed ID: 34046851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do we need another symptom score for childhood eczema?
    Hon KL; Kung JSC; Tsang KYC; Yu JWS; Cheng NS; Leung TF
    J Dermatolog Treat; 2018 Aug; 29(5):510-514. PubMed ID: 28849683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis.
    Simpson EL; de Bruin-Weller M; Eckert L; Whalley D; Guillemin I; Reaney M; Chen Z; Nelson L; Qin S; Bansal A; Gadkari A
    Dermatol Ther (Heidelb); 2019 Dec; 9(4):799-805. PubMed ID: 31641952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life.
    Coutanceau C; Stalder JF
    Dermatology; 2014; 229(3):248-55. PubMed ID: 25196258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of patient-reported global severity of atopic dermatitis in adults.
    Vakharia PP; Chopra R; Sacotte R; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Silverberg JI
    Allergy; 2018 Feb; 73(2):451-458. PubMed ID: 28905999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of atopic dermatitis severity with cognitive function in adults.
    Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY; Cella D
    J Am Acad Dermatol; 2020 Nov; 83(5):1349-1359. PubMed ID: 32428607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.